HARRISBURG — Attorney General Dave Sunday joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma, and Mayne Pharma to resolve allegations that the generic drug manufacturers engaged in a widespread, long-running conspiracy to increase prices and cut consumer options.
Specifically, the settlements relate to alleged behaviors by the companies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade of generic prescription drugs.
Per the settlements, the companies each agreed to meaningful injunctive terms, including a series of internal reforms to ensure fair competition and compliance with antitrust laws. Additionally, Ascend and Mayne will pay $400,000 and $650,000, respectively, to the states.
“This is the latest action in this national coalition’s fight to hold accountable companies, large and small, who harmed consumers in need of medications that keep them well,” Attorney General Sunday said. “By limiting market competition while inflating prices, Pennsylvanians had no recourse but to pay unfair prices manipulated by these manufacturers.”
These latest settlements come as the states prepare for the first trial to be held in Hartford, Connecticut in February 2027.
The States previously reached settlements with Sandoz, Glenmark, Lannett, Bausch, Apotex and Heritage, and Heritage’s parent company, Emcure, totaling $496.5 million.
If you purchased a generic prescription drug between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com. You can submit a claim for compensation here.
The cases all stem from a series of investigations built on evidence from several cooperating witnesses at the core of the different conspiracies, a massive document database of over 20 million documents, and a phone records database containing millions of call detail records and contact information for over 600 sales and pricing individuals in the generics industry.
States and territories joining the settlements include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
###